Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2024-08-16 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Consolidated Interim Report 1 January – 30 June 2024
Regulatory Filings
2024-08-16 Danish
Consolidated Interim Report 1 January – 30 June 2024
Interim / Quarterly Report Classification · 100% confidence The document is a 'Consolidated interim report' for the 6-month period ended 30 June 2024. It contains comprehensive financial statements, including the consolidated statement of comprehensive income, financial position, changes in equity, and cash flow statement, along with management's review and notes. It is not an announcement of a report, but the report itself, and it covers a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2024
2024-08-16 English
Consolidated Interim Report 1 January – 30 June 2024
Report Publication Announcement Classification · 95% confidence The document is a short announcement (Company announcement no. 23) regarding the release of the H1-2024 interim report. It provides a summary of key financial highlights and business updates but explicitly lists the full interim report as an 'Attachment' at the end of the text. Following the 'Menu vs Meal' rule, this document serves as an announcement of the report's publication rather than the report itself. H1 2024
2024-08-16 Danish
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document is titled "Storaktionærmeddelelse" (Major Shareholder Announcement) and explicitly states that Finansmanagement ApS has acquired shares, increasing their ownership from under 5% to 19.57% as of July 11, 2024, referencing the Danish Capital Markets Act (§ 38). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The appropriate code is MRQ.
2024-07-15 Danish
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major shareholder announcement" and details a change in ownership stake by Finansmanagement ApS in Pharma Equity Group A/S, referencing Section 38 of the Capital Markets Act. This directly corresponds to the definition of a Major Shareholding Notification. The document is short and appears to be the announcement itself, not a comprehensive report. Therefore, the appropriate code is MRQ.
2024-07-15 English
Major shareholder announcement - Pharma Equity Group A/S
Major Shareholding Notification Classification · 100% confidence The document is a 'Storaktionærmeddelelse' (Major Shareholder Notification) from Pharma Equity Group A/S. It explicitly states that a shareholder (Finansmanagement ApS) has crossed a reporting threshold (increasing ownership from under 5% to 19.57%). This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2024-07-15 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.